Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Breast Cancer | VuMedi

Dana-Farber Cancer Institute

Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Breast Cancer

By Dana-Farber Cancer Institute FEATURING Sara Tolaney

By Dana-Farber Cancer Institute FEATURING Sara Tolaney

0 views

September 24, 2019

Comments 1

Login to view comments. Click here to Login